Article abstract
Nature Immunology 8, 1246 - 1254 (2007)
Published online: 30 September 2007 | doi:10.1038/ni1515
Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction
Daniel E Kaufmann1,7, Daniel G Kavanagh1,7, Florencia Pereyra1,2, John J Zaunders3, Elizabeth W Mackey1, Toshiyuki Miura1,4, Sarah Palmer5, Mark Brockman1,4, Almas Rathod1, Alicja Piechocka-Trocha1,4, Brett Baker1, Baogong Zhu6, Sylvie Le Gall1, Michael T Waring1,4, Ryan Ahern1, Kristin Moss1, Anthony D Kelleher3, John M Coffin5, Gordon J Freeman6, Eric S Rosenberg1 & Bruce D Walker1,4
Abstract
In progressive viral infection, antiviral T cell function is impaired by poorly understood mechanisms. Here we report that the inhibitory immunoregulatory receptor CTLA-4 was selectively upregulated in human immunodeficiency virus (HIV)–specific CD4+ T cells but not CD8+ T cells in all categories of HIV-infected subjects evaluated, with the exception of rare people able to control viremia in the absence of antiretroviral therapy. CTLA-4 expression correlated positively with disease progression and negatively with the capacity of CD4+ T cells to produce interleukin 2 in response to viral antigen. Most HIV-specific CD4+ T cells coexpressed CTLA-4 and another inhibitory immunoregulatory receptor, PD-1. In vitro blockade of CTLA-4 augmented HIV-specific CD4+ T cell function. These data, indicating a reversible immunoregulatory pathway selectively associated with CD4+ T cell dysfunction, provide a potential target for immunotherapy in HIV-infected patients.
- Partners AIDS Research Center, Massachusetts General Hospital and Division of AIDS, Harvard Medical School, Boston, Massachusetts 02115, USA.
- Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
- Centre for Immunology, St Vincent's Hospital, Darlinghurst, New South Wales 2010, Australia.
- Howard Hughes Medical Institute, Chevy Chase, Maryland 20185, USA.
- HIV Drug Resistance Program, National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702, USA.
- Department of Medical Oncology, Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA.
- These authors contributed equally to this work.
Correspondence to: Daniel E Kaufmann1,7 e-mail: dkaufmann@partners.org
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Inhibitory receptors: whose side are they on?Nature Immunology News and Views (01 Nov 2007)
Dangerous T-cell amnesiaNature Medicine News and Views (01 May 1999)
See all 5 matches for News And ViewsRESEARCH
Indirect measurement of lymphatic absorption in CAPD patients is not influenced by trappingKidney International Original Article
Skewed maturation of memory HIV-specific CD8 T lymphocytesNature Letters to Editor (01 Mar 2001)
See all 56 matches for Research
